Abstract: OBJECTIVE To discuss the pharmaceutical care model on the patient with cutaneous anthrax of malignant edema. METHODS According to the characteristics of drug therapy on the patient with cutaneous anthrax of malignant edema, the pharmaceutical care was carried out and the suggestions on the pharmacy were given. RESULTS Through the pharmaceutical care, the safety, reasonable and effectiveness were improved. And also, the incidence rate of adverse drug reaction was decreased. CONCLUSION The clinical pharmacists develop actively pharmaceutical service and optimize dosage regimen cooperating with the clinical physician, which is beneficial to the safety, reasonable and effectiveness of drug therapy on the patients.